Joseph Horrigan
Director Técnico/Científico/I+D en AMO Pharma Ltd. .
Cargos activos de Joseph Horrigan
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - | - |
AMO Pharma Ltd.
 AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Director Técnico/Científico/I+D | - | - |
Historial de carrera de Joseph Horrigan
Antiguos cargos conocidos de Joseph Horrigan.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Director Técnico/Científico/I+D | 10/08/2012 | - |
Formación de Joseph Horrigan.
| Rochester Christian University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Australia | 2 |
| Reino Unido | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Health Technology |
| Empresas privadas | 1 |
|---|---|
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Joseph Horrigan
- Experiencia
